Belite Bio, Inc. · NASDAQ:BLTE
Scholl Hendrik Peter sold 2,000 Belite Bio, Inc. shares (Form 4)
Traded Nov 12, 2026 · Filed Nov 16, 2026
On Nov 12, 2026, Scholl Hendrik Peter (Chief Medical Officer) sold 2,000 Belite Bio, Inc. shares at an average US$165.99 for US$332K under a trading plan, leaving 12,500 shares. Filed Nov 16, 2026 (Form 4).
- Sold
- 2,000 shares
- Price
- US$165.99 average (US$162.04 to US$170.41)
- Value
- US$332K
- Holding after
- 12,500 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | American depositary share | Sale | 500 | US$162.04 | 14,000 | Indirect |
| Nov 12, 2026 | American depositary share | Sale | 500 | US$164.68 | 13,500 | Indirect |
| Nov 12, 2026 | American depositary share | Sale | 500 | US$166.82 | 13,000 | Indirect |
| Nov 12, 2026 | American depositary share | Sale | 500 | US$170.41 | 12,500 | Indirect |
Source
Download original · View original at SEC